Abstract
In a follow-up article,1 we divided the children into two groups for the purpose of analysis. In the first group were children with a single, brief, generalized initial febrile seizure and no history of prenatal, perinatal, or postnatal abnormalities that might suggest the possibility of brain damage. In the second group were those children with such birth abnormalities, and/or a severe initial febrile convulsion, and/or abnormal results of neurological examination. In the first group, the 36-month recurrence rates were 5% for those randomly assigned to continuous phenobarbital therapy and 34% for those receiving intermittent or no phenobarbital therapy (P > .001).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
